Medical News

RSS

Final health care package shaped by changing political landscape

Kaiser Health News staff writer Jordan Rau writes: "In the year it took Congress to write and pass a health care overhaul, turbulent political shifts — including the Democrats' loss of Sen. Edward Kennedy's seat and the rise of the Tea Party movement — forced critical compromises on the scope of legislation"

25 Mar 2010

CBAI acquires majority stake in stellacure GmbH

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, announced today that it has acquired 51 percent of stellacure GmbH, the third largest cord blood banking service in Germany.

25 Mar 2010

Alzheimer's Foundation of America applauds dementia-related provisions in health reform law

The Alzheimer's Foundation of America (AFA) is extremely pleased that the historic health reform signed into law by President Obama late this morning, after passing the U.S. House of Representatives on Sunday and the U.S. Senate in December, includes a number of provisions that are especially significant for AFA's constituents—and bode well for improving quality of life for individuals with Alzheimer's disease and related dementias, and their family caregivers. In particular, we are grateful that the final action addresses many of the practical and financial needs faced daily by this population, speaks to preventative issues and bolsters training of dementia care professionals.

25 Mar 2010

Controversy brews on new law's provisions on health coverage for Congress members, staff

The health care reform bill signed into law by President Barack Obama Tuesday requires members of Congress and their office staffs to buy insurance through the state-run exchanges it creates - but it may exempt staffers who work for congressional committees or for party leaders in the House and Senate.

25 Mar 2010

Hepatic encephalopathy drug XIFAXAN 550 mg tablets receives FDA marketing approval

Salix Pharmaceuticals, Ltd. today announced the U.S. Food and Drug Administration has granted marketing approval for XIFAXAN 550 mg tablets for reduction in risk of overt hepatic encephalopathy recurrence in patients 18 years of age or older. HE is a serious disorder caused by chronic liver failure, resulting in cognitive, psychiatric and motor impairments. This approval was supported by findings from the largest randomized trial of maintenance therapy in HE conducted to date, which assessed the efficacy and safety of XIFAXAN 550 mg tablets and demonstrated a statistically significant and clinically meaningful reduction in the risk of overt HE recurrence.

25 Mar 2010

US patent reinforces Ikonisys' position in digital image-analysis industry

Ikonisys, Inc., a leading provider of next-generation, cell-based diagnostic solutions, announced today that the United States Patent and Trademark Office has issued the company United States Patent No. 7,660,454 entitled “Process for identifying FISH signals.”

25 Mar 2010

NHS needs to gear up in terms of productivity, say statisticians

In an alarming new revelation, the productivity of National Health Service NHS, has dropped steadily from 2001 by 0.4% each year and a total of 3%. 2008 has seen the largest fall, 0.7% according to the Office for National Statistics, ONS.

25 Mar 2010

Breastfeeding expert offers tips for choosing right feeding bottles

Breastfeeding expert Donna Dowling, associate professor of nursing at the Frances Payne Bolton School of Nursing at Case Western Reserve University, could sympathize with the new mom next to her in a large baby store as she was also overwhelmed by the variety of bottle choices in the 12 x 8 foot display.

25 Mar 2010

Women from poor backgrounds have worse breast cancer outcomes

The largest study in Europe to look at the link between socioeconomic status and survival after breast cancer has found that women from poorer backgrounds have worse outcomes and that this is only partly explained by more advanced cancer at diagnosis.

25 Mar 2010

Cardiologist receives grant to study impact of erectile dysfunction drugs on muscular dystrophy patients

A Cedars-Sinai Heart Institute cardiologist has been awarded a three-year, nearly $1 million grant from the Muscular Dystrophy Association (MDA) to study whether drugs used to treat erectile dysfunction could also be used to improve muscle blood flow and reduce fatigue in muscular dystrophy patients.

25 Mar 2010

Biocompatible electronics could enable new surgical applications

Arrhythmic hearts soon may beat in time again, with minimal surgical invasion, thanks to flexible electronics technology developed by a team of University of Illinois researchers, in collaboration with the University of Pennsylvania School of Medicine and Northwestern University.

25 Mar 2010

Campylobacter cells can survive with biofilm protection

In research published in the journal Applied and Environmental Microbiology, IFR researchers have found that Campylobacter will readily form a biofilm under laboratory conditions, and that, when the bacteria were left in air, they respond to these stressful conditions by more rapidly forming this biofilm.

25 Mar 2010

Looking back: Moments that shifted health reform conversation

Kaiser Health News reports on the "critical compromises" and events that shaped the final version of the health care reform bill, including the Democratic loss of Sen. Ted Kennedy's seat and the rise of the Tea Party movement.

25 Mar 2010

AGA Medical gets IDE approval to evaluate AMPLATZER Cardiac Plug

AGA Medical Holdings, Inc. today announced it has received conditional Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration to evaluate the safety and efficacy of its AMPLATZER® Cardiac Plug, or ACP, to close the left atrial appendage.

25 Mar 2010

Changing drug therapy can help breast cancer patients get full benefit of Tamoxifen

Recently published research has shown that some breast cancer patients taking tamoxifen may not be getting the full benefit of their treatment because they have also been taking selective serotonin reuptake inhibitors (SSRIs), prescribed drugs that inhibit the effect of an important enzyme. Now researchers have developed a strategy for overcoming this problem, the seventh European Breast Cancer Conference (EBCC7) in Barcelona will hear today (Wednesday).

25 Mar 2010

American Lung Association in California supports efforts for quality TB care

Tuberculosis (TB) continues to be a serious public health threat in the U.S. with nearly 13,000 TB cases reported during 2008.

25 Mar 2010

Head trauma can cause loss of smell and taste sensations

The ability to taste and smell can be lost or impaired after a head injury, according to a new study by scientists from the Universit- de Montr-al, the Lucie Bruneau Rehabilitation Centre, as well as the Center for Interdisciplinary Research in Rehabilitation of Greater Montreal. Published in the journal Brain Injury, the investigation established that mild to severe traumatic brain injury could cause olfactory loss.

25 Mar 2010

300,000 extra GP visits for children due to passive smoking - time to make cars and homes smoke free

Doctors have urged an immediate review of the anti-smoking laws in light of such alarming facts. They want a ban on smoking in public places and cars.

25 Mar 2010

Clinical data of dendritic cell based vaccine to be presented at Cancer Stem Cells Conference

ImmunoCellular Therapeutics announced today that Manish Singh, Ph.D., President and CEO, will be presenting at the Cancer Stem Cells Conference, a leading industry event, on Wednesday, March 24th at 2:00 p.m. eastern time.

25 Mar 2010

Anesthesia can increase behavioral changes, risk of developing Alzheimer's disease

The use of repetitive anesthesia with isoflurane (one of the most common anesthetics by inhalation) increases the risk of developing changes similar to those observed in AD brains in mice with mutations of the amyloid precursor protein (APP). This is the main conclusion of Spanish researchers coordinated by Doctors Maria -ngeles Mena and Justo Garc-a de Y-benes, from CIBERNED (Centro de Investigaci-n Biom-dica en Red de Enfermedades Neurodegenerativas).

25 Mar 2010

Medical News

Final health care package shaped by changing political landscape

CBAI acquires majority stake in stellacure GmbH

Alzheimer's Foundation of America applauds dementia-related provisions in health reform law

Controversy brews on new law's provisions on health coverage for Congress members, staff

Hepatic encephalopathy drug XIFAXAN 550 mg tablets receives FDA marketing approval

US patent reinforces Ikonisys' position in digital image-analysis industry

NHS needs to gear up in terms of productivity, say statisticians

Breastfeeding expert offers tips for choosing right feeding bottles

Women from poor backgrounds have worse breast cancer outcomes

Cardiologist receives grant to study impact of erectile dysfunction drugs on muscular dystrophy patients

Biocompatible electronics could enable new surgical applications

Campylobacter cells can survive with biofilm protection

Looking back: Moments that shifted health reform conversation

AGA Medical gets IDE approval to evaluate AMPLATZER Cardiac Plug

Changing drug therapy can help breast cancer patients get full benefit of Tamoxifen

American Lung Association in California supports efforts for quality TB care

Head trauma can cause loss of smell and taste sensations

300,000 extra GP visits for children due to passive smoking - time to make cars and homes smoke free

Clinical data of dendritic cell based vaccine to be presented at Cancer Stem Cells Conference

Anesthesia can increase behavioral changes, risk of developing Alzheimer's disease

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News